S-(N-4bromophenyl-N-hydroxycarbamoyl)glutathione

ID: ALA128872

Chembl Id: CHEMBL128872

Cas Number: 156727-62-7

PubChem CID: 448107

Max Phase: Preclinical

Molecular Formula: C17H21BrN4O8S

Molecular Weight: 521.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@@H](CCC(=O)N[C@@H](CSC(=O)N(O)c1ccc(Br)cc1)C(=O)NCC(=O)O)C(=O)O

Standard InChI:  InChI=1S/C17H21BrN4O8S/c18-9-1-3-10(4-2-9)22(30)17(29)31-8-12(15(26)20-7-14(24)25)21-13(23)6-5-11(19)16(27)28/h1-4,11-12,30H,5-8,19H2,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t11-,12-/m0/s1

Standard InChI Key:  IQPLOQWSCZRUCA-RYUDHWBXSA-N

Alternative Forms

Associated Targets(Human)

GLO1 Tchem Glyoxalase I (402 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GLO1 Lactoylglutathione lyase (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.35Molecular Weight (Monoisotopic): 520.0263AlogP: 0.38#Rotatable Bonds: 11
Polar Surface Area: 199.36Molecular Species: ZWITTERIONHBA: 8HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.72CX Basic pKa: 9.36CX LogP: -2.80CX LogD: -6.12
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.17Np Likeness Score: 0.04

References

1. Kalsi A, Kavarana MJ, Lu T, Whalen DL, Hamilton DS, Creighton DJ..  (2000)  Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I.,  43  (21): [PMID:11052803] [10.1021/jm000160l]
2. More SS, Vince R..  (2006)  A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I.,  16  (23): [PMID:16997560] [10.1016/j.bmcl.2006.08.121]
3. More SS, Vince R..  (2009)  Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors.,  52  (15): [PMID:19610604] [10.1021/jm900382u]
4. Sang Y, Shi Q, Mo M, Ni C, Li Z, Liu B, Deng Q, Creighton DJ, Zheng ZB..  (2015)  Novel bivalent inhibitors with sub-nanomolar affinities towards human glyoxalase I.,  25  (21): [PMID:26320622] [10.1016/j.bmcl.2015.08.055]
5. Jin T, Zhao L, Wang HP, Huang ML, Yue Y, Lu C, Zheng ZB..  (2020)  Recent advances in the discovery and development of glyoxalase I inhibitors.,  28  (4): [PMID:31879183] [10.1016/j.bmc.2019.115243]

Source